Verastem, Inc. (VSTM)
NASDAQ: VSTM · Real-Time Price · USD
5.55
+0.25 (4.72%)
At close: Apr 1, 2026, 4:00 PM EDT
5.57
+0.02 (0.27%)
Pre-market: Apr 2, 2026, 6:32 AM EDT
Verastem Market Cap
Verastem has a market cap or net worth of $487.48 million as of April 2, 2026. Its market cap has increased by 51.49% in one year.
Market Cap
487.48M
Enterprise Value
369.66M
1-Year Change
51.49%
Ranking
Category
Stock Price
$5.55
Market Cap Chart
Since January 27, 2012, Verastem's market cap has increased from $213.30M to $487.48M, an increase of 128.54%. That is a compound annual growth rate of 6.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2026 | 465.50M | -9.70% |
| Dec 31, 2025 | 515.50M | 124.03% |
| Dec 31, 2024 | 230.10M | 11.86% |
| Dec 29, 2023 | 205.70M | 143.14% |
| Dec 30, 2022 | 84.60M | -77.35% |
| Dec 31, 2021 | 373.50M | 3.29% |
| Dec 31, 2020 | 361.60M | 263.05% |
| Dec 31, 2019 | 99.60M | -59.81% |
| Dec 31, 2018 | 247.80M | 99.36% |
| Dec 29, 2017 | 124.30M | 200.24% |
| Dec 30, 2016 | 41.40M | -39.74% |
| Dec 31, 2015 | 68.70M | -70.98% |
| Dec 31, 2014 | 236.70M | -19.05% |
| Dec 31, 2013 | 292.40M | 56.53% |
| Dec 31, 2012 | 186.80M | -12.42% |
| Jan 27, 2012 | 213.30M | - |
View and export this data all the way back to 2012. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lyell Immunopharma | 457.99M |
| Kyverna Therapeutics | 457.04M |
| Immix Biopharma | 452.32M |
| Larimar Therapeutics | 450.85M |
| Fulcrum Therapeutics | 448.55M |
| Nautilus Biotechnology | 442.98M |
| Entrada Therapeutics | 436.32M |
| Shattuck Labs | 434.39M |